Viewing Study NCT01117103


Ignite Creation Date: 2025-12-24 @ 7:14 PM
Ignite Modification Date: 2025-12-25 @ 4:50 PM
Study NCT ID: NCT01117103
Status: COMPLETED
Last Update Posted: 2014-07-16
First Post: 2010-05-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Prospective, Observational Study to Assess and Evaluate the Use of Glucophage XR Therapy in the Management of Patients With Type 2 Diabetes
Sponsor: Merck KGaA, Darmstadt, Germany
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module